Dothprime 50 Tablet contains Dothiepin 50 mg, a tricyclic antidepressant used for the treatment of moderate to severe depressive disorders and anxiety conditions. It helps improve mood, emotional stability, and overall mental well-being.
Dothiepin acts by modulating key neurotransmitters including serotonin and norepinephrine, which are essential for regulating mood and emotional responses. This mechanism helps reduce depressive symptoms, anxiety, and associated sleep disturbances, supporting consistent mental health improvement.
Clinically, Dothprime 50 Tablet is prescribed for depression, anxiety disorders, psychosomatic complaints, and chronic emotional stress, offering reliable therapeutic outcomes and patient compliance when taken as directed.
From a portfolio perspective, Dothprime 50 Tablet reinforces the psychiatry and mental health therapy segment, with regular demand across psychiatric clinics, hospitals, and general practice settings, contributing to long-term prescription continuity.